No Representation of Licensed Patent. also acknowledges that Stanford does not represent or warrant: (A) the validity or scope of any Licensed Patent; or (B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 21 contracts
Sources: Exclusive License Agreement, Exclusive License Agreement, Nonexclusive License Agreement
No Representation of Licensed Patent. also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 6 contracts
Sources: Exclusive License Agreement, Exclusive License Agreement, Exclusive License Agreement
No Representation of Licensed Patent. Company also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 4 contracts
Sources: Exclusive (Equity) Agreement (Ceribell, Inc.), Exclusive (Equity) Agreement (Ceribell, Inc.), Exclusive Agreement
No Representation of Licensed Patent. Company also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 3 contracts
Sources: Nonexclusive License Agreement, Nonexclusive License Agreement, Nonexclusive License Agreement
No Representation of Licensed Patent. Forty Seven also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent Patent, Licensed Information or Licensed Technology will be successful.
Appears in 3 contracts
Sources: Exclusive Agreement (Forty Seven, Inc.), Exclusive Agreement (Forty Seven, Inc.), Exclusive (Equity) Agreement (Forty Seven, Inc.)
No Representation of Licensed Patent. Annexon also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; , or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 2 contracts
Sources: Exclusive Agreement (Annexon, Inc.), Exclusive Agreement (Annexon, Inc.)
No Representation of Licensed Patent. LogicBio also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 2 contracts
Sources: Exclusive (Equity) Agreement (LogicBio Therapeutics, Inc.), Exclusive (Equity) Agreement (LogicBio Therapeutics, Inc.)
No Representation of Licensed Patent. Licensee also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; , or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 2 contracts
Sources: Exclusive (Equity) Agreement, Exclusive (Equity) Agreement
No Representation of Licensed Patent. BioTrove also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; , or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 2 contracts
Sources: Exclusive Agreement (BioTrove, Inc.), Exclusive Agreement (BioTrove, Inc.)
No Representation of Licensed Patent. FAB also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; , or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 2 contracts
Sources: Exclusive Patent License and Research Collaboration Agreement (Sutro Biopharma Inc), Exclusive Agreement (Sutro Biopharma Inc)
No Representation of Licensed Patent. Medicenna also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 2 contracts
Sources: Exclusive Equity Agreement (Medicenna Therapeutics Corp.), Exclusive Equity Agreement
No Representation of Licensed Patent. RUGA also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; , or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 2 contracts
Sources: Exclusive License Agreement (Versartis, Inc.), Exclusive License Agreement (Versartis, Inc.)
No Representation of Licensed Patent. Sutro also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; , or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 2 contracts
Sources: License Agreement, License Agreement (Sutro Biopharma Inc)
No Representation of Licensed Patent. Epinomics also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 2 contracts
Sources: Exclusive (Equity) Agreement (10x Genomics, Inc.), Exclusive (Equity) Agreement (10x Genomics, Inc.)
No Representation of Licensed Patent. also Each Licensee acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; , or
(B) that the exploitation of Licensed Patent or Technology Patents will be successful.
Appears in 2 contracts
Sources: Co Exclusive License Agreement, Co Exclusive License Agreement (Regulus Therapeutics Inc.)
No Representation of Licensed Patent. Surrozen also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 1 contract
Sources: Exclusive License Agreement (Consonance-HFW Acquisition Corp.)
No Representation of Licensed Patent. Alto also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 1 contract
Sources: Exclusive License Agreement (Alto Neuroscience, Inc.)
No Representation of Licensed Patent. Combangio also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 1 contract
Sources: Exclusive License Agreement (Kala Pharmaceuticals, Inc.)
No Representation of Licensed Patent. VIA also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; , or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 1 contract
No Representation of Licensed Patent. ▇▇▇▇▇▇▇▇▇ also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 1 contract
Sources: Exclusive Equity Agreement (Medicenna Therapeutics Corp.)
No Representation of Licensed Patent. FivePrime also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or the Technology will be successful.
Appears in 1 contract
Sources: Non Exclusive License Agreement (Five Prime Therapeutics Inc)
No Representation of Licensed Patent. Jasper also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 1 contract
Sources: Exclusive License Agreement (Amplitude Healthcare Acquisition Corp)
No Representation of Licensed Patent. AKOYA also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of any Licensed Patent or Technology will be successful.
Appears in 1 contract
Sources: Exclusive (Equity) Agreement (Akoya Biosciences, Inc.)
No Representation of Licensed Patent. Lyell also acknowledges that Stanford does not represent or warrant:
(Aa) the validity or scope of any Licensed Patent; or
(Bb) that the exploitation of Licensed Patent or Technology IP Rights will be successful.
Appears in 1 contract
No Representation of Licensed Patent. Aditxt also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 1 contract
Sources: Exclusive License Agreement (ADiTx Therapeutics, Inc.)
No Representation of Licensed Patent. Company also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology Patents will be successful.
Appears in 1 contract
Sources: Exclusive (Equity) Agreement (AbCellera Biologics Inc.)
No Representation of Licensed Patent. Purigen also acknowledges that Stanford does not represent or warrant:
(A) the validity or scope of any Licensed Patent; or
(B) that the exploitation of Licensed Patent or Technology will be successful.
Appears in 1 contract
Sources: Exclusive License Agreement (Bionano Genomics, Inc.)